Chronic myelogenous leukemia secondary to colon cancer: A case report. [PDF]
Li XL +6 more
europepmc +1 more source
Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia. [PDF]
Yoshifuji K, Sasaki K.
europepmc +1 more source
Pathogenesis of chronic myelogenous leukemia
G Bergamaschi, V Rosti
doaj +1 more source
Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation. [PDF]
Lugin ML +8 more
europepmc +1 more source
Prostate cancer, chronic myelogenous leukemia and multiple myeloma in a single patient: a case report and review of the literature. [PDF]
Allahyari A +3 more
europepmc +1 more source
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation. [PDF]
Wu JH +27 more
europepmc +1 more source
AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects. [PDF]
Gayatri MB +6 more
europepmc +1 more source
An interesting case of coexistence of autosomal dominant hypocalcemia 1 with Bartter syndrome and chronic myelogenous leukemia. [PDF]
Chondrogianni ME +9 more
europepmc +1 more source
Expression profiles of miR-411 and SPRY4 as indicators of disease progression and treatment in chronic myelogenous leukemia. [PDF]
Shabannezhad A +5 more
europepmc +1 more source

